Derycz Amends Research Solutions Ownership Filing

TL;DR

Derycz filed an update on his stake in Research Solutions, Inc. (RSOI).

AI Summary

Peter Derycz filed an amendment (No. 8) to Schedule 13D on July 25, 2024, for Research Solutions, Inc. The filing indicates a change in beneficial ownership of the company's common stock. Derycz's address is listed as 2355 Westwood Blvd., Suite 739, Los Angeles, CA 90064.

Why It Matters

This filing updates information regarding significant beneficial ownership, which can signal changes in control or investment strategy for Research Solutions, Inc.

Risk Assessment

Risk Level: medium — Schedule 13D filings often relate to significant ownership changes, which can indicate potential shifts in company control or strategy, carrying inherent investment risk.

Key Players & Entities

• Peter Derycz (person) — Filing person and beneficial owner
• Research Solutions, Inc. (company) — Subject company
• 2355 Westwood Blvd., Suite 739, Los Angeles, CA 90064 (address) — Peter Derycz's mailing address
• July 25, 2024 (date) — Date of event requiring filing

FAQ

Key Financial Figures

• $0.001 — Inc. (Name of Issuer) Common stock, $0.001 par value per share (Title of Class o

Filing Documents

• deryzc_13da8.htm (SC 13D/A) — 41KB
• 0001683168-24-005068.txt ( ) — 43KB

Security and Issuer

Item 1. Security and Issuer. This Schedule 13D relates to the common stock, par value $0.001 per share (the “Common Stock”), of Research Solutions, Inc., a Nevada corporation (the “Company”), which has its principal executive offices at 5435 Balboa Boulevard, Suite 202, Encino, California 91316.

Identity and Background

Item 2. Identity and Background. This statement is being filed by Peter Derycz, a citizen of the United States of America (the “Reporting Person”).

Purpose of Transaction

Item 4. Purpose of Transaction. Reference is made to the disclosure set forth under Item 3 of this Schedule 13D, which disclosure is incorporated herein by reference. The shares of Common Stock to which this Schedule 13D relates are held by the Reporting Person as an investment. The Reporting Person disclaims any membership in a group relating to the Company. The Reporting Person is not aware of any plans or proposals which would result in the acquisition by any person of additional securities of the Company or the disposition of securities of the Company; any extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Company or any of its subsidiaries; a sale or transfer of a material amount of assets of the Company or any of its subsidiaries; any change in the present board of directors or management of the Company, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the Company's board of directors; any material change in the present capitalization or dividend policy of the Company; any other material change in the Company's business or corporate structure; any changes in Company's charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Company by any person; causing a class of securities of the Company to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; a class of equity securities of the Company becoming eligible for termination of registration pursuant to section 12(g)(4) of the Act; or any action similar to any of those enumerated above.

Interest in Securities of the Issuer

Item 5. Interest in Securities of the Issuer.

of Schedule 13D is

Item 5 of Schedule 13D is supplemented and amended by the information below. Reference is made to the disclosure set forth under Item 3 of this Schedule 13D/A, which disclosure is incorporated herein by reference. The Reporting Person has the sole power vote or direct the vote of, and to dispose of or direct the disposition of all shares beneficially owned by the Reporting Person.

Contracts, Arrangements,

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. Reference is made to the disclosure set forth under Items 3, 4 and 5 of this Schedule 13D, which disclosure is incorporated herein by reference.

Material to be Filed as Exhibits

Item 7. Material to be Filed as Exhibits. None. 3

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of his knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: July 25, 2024 /s/ Peter Derycz PETER DERYCZ 4

View Full Filing

View this SC 13D/A filing on SEC EDGAR